Search

everythinglearnresearchcommunity

for

Search:↓

Phytosterols may help manage prostate issues but are less effective than synthetic drugs.

Finasteride treatment may cause erectile dysfunction, but stopping it reverses these effects.

Finasteride increases P-glycoprotein activity in the liver and kidney.

Certain derivatives are more effective 5α-reductase type 2 inhibitors than finasteride.

5alpha-reductase inhibitors like finasteride and dutasteride effectively treat BPH by reducing DHT, offering symptom relief and potential future uses.

Five-alpha reductase inhibitors, like finasteride and dutasteride, can treat enlarged prostates, improve urination, reduce need for prostate surgery, and lower the risk of prostate cancer, but may increase the risk of higher grade prostate cancer. They can also treat male pattern baldness.

New treatments for enlarged prostate are being developed, some of which may be more effective than current medications.

Taking both finasteride and dutasteride for prostate issues may raise the risk of heart problems.

Researchers developed a model to predict how well certain compounds can block an enzyme related to hair loss and prostate issues, suggesting a 50 mg dose of finasteride might be effective based on lab and body data.

New research is needed to create better drugs that block the enzyme responsible for conditions like male baldness and prostate enlargement.

Finasteride is a safe and effective long-term treatment for prostate enlargement, reducing prostate volume and related symptoms.

SPET-085 effectively inhibits an enzyme linked to prostate issues, similar to finasteride.

Dutasteride more effectively lowers DHT levels in men with enlarged prostates than finasteride.

Men on 5-alpha-reductase inhibitors might have worse COVID-19 outcomes.

The effectiveness of platelet-rich plasma for erectile dysfunction is still unclear.

Medications for enlarged prostate can cause sexual side effects like reduced libido, erectile dysfunction, and ejaculatory problems.

PNU157706 reduced rat sperm movement and fertility without affecting offspring health.

The method is quick and effective for testing steroid 5 alpha-reductase inhibitors.

Men taking dutasteride may have a higher risk of age-related macular degeneration.

Finasteride effectively treats benign prostatic hyperplasia by reducing prostate size and improving urinary symptoms.

5α-reductase inhibitors can cause serious and possibly lasting sexual and psychological side effects.

Using finasteride for hair loss or prostate issues does not significantly raise the risk of erectile dysfunction.

GI198745 is more potent and longer-lasting than finasteride, potentially better for treating hair loss.

Finasteride may be linked to Peyronie’s disease, but more research is needed.

Finasteride may help improve certain brain function issues linked to dopamine.

Certain medications, especially 5-α reductase inhibitors and neuropsychiatric drugs, are often linked to erectile dysfunction.

Inhibiting 5α-reductase can help reduce prostate cancer risk and improve treatment.

Finasteride improves heart function in obese and aging male rats by reducing oxidative stress and p53 protein levels.

Long-term treatment with finasteride or combined therapy worsens sexual function in men with urinary issues.

Some patients may experience lasting sexual dysfunction, depression, and other side effects from 5α-reductase inhibitor therapy.